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Abstract: Apoptotic cells (AC) must be cleared by
macrophages (Mø) to resolve inflammation effec-
tively. Mertk and scavenger receptor A (SR-A) are
two of many receptors involved in AC clearance.
As SR-A lacks enzymatic activity or evident intra-
cellular signaling motifs, yet seems to signal in
some cell types, we hypothesized that SR-A signals
via Mer receptor tyrosine kinase (Mertk), which
contains a multisubstrate docking site. We induced
apoptosis in murine thymocytes by dexamethasone
and used Western blotting and immunoprecipita-
tion to analyze the interaction of Mertk and SR-A in
the J774A.1 (J774) murine Mø cell line and in
peritoneal Mø of wild-type mice and SR-A/
mice. Phagocytosis (but not adhesion) of AC by
J774 was inhibited by anti-SR-A or function-block-
ing SR-A ligands. In resting J774, SR-A was asso-
ciated minimally with unphosphorylated (mono-
meric) Mertk; exposure to AC induced a time-
dependent increase in association of SR-A with
Mertk in a direct or indirect manner. Anti-SR-A
inhibited AC-induced phosphorylation of Mertk
and of phospholipase C2, essential steps in AC
ingestion. Relative to tissue Mø of wild-type mice,
AC-induced Mertk phosphorylation was reduced
and delayed in tissue Mø of SR-A/ mice, as was
in vitro AC ingestion at early time-points. Thus,
during AC uptake by murine Mø, SR-A is essential
for optimal phosphorylation of Mertk and subse-
quent signaling required for AC ingestion. These
data support the Mertk/SR-A complex as a poten-
tial target to manipulate AC clearance and hence,
resolution of inflammation and infections. J. Leu-
koc. Biol. 84: 510–518; 2008.
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INTRODUCTION
Efficient clearance of apoptotic leukocytes in resolving inflam-
mation is vital to minimize tissue injury and to avoid the risk
of autoimmunity as a result of inappropriate presentation of
self-antigens [1–3]. In some organs, apoptotic cells (AC) can
clearly be ingested by cell types other than macrophages (Mø),
especially certain specialized epithelial cells [4–7]. In the
lungs, a frequent site of infection and inflammatory diseases,
epithelial cells and fibroblasts ingest AC in vitro, albeit less
efficiently than do Mø [8–10]. However, during steady-state in
most organs and certainly during resolving inflammation,
mononuclear phagocytes are believed to clear most AC. Im-
portantly, Mø that contact AC assume a unique activation state
[11–18] and elaborate TGF- and PGE2 [13, 19]. These im-
munosuppressive mediators hasten the resolution of inflamma-
tion from successfully managed infections [20] but also have
the potential to compromise host defenses against subsequent
pathogens and to promote fibrosis [21–25]. Thus, understand-
ing the molecular mechanisms mediating Mø ingestion of AC
has significant implications for multiple areas of biology and
medicine.
No current model comprehensively explains Mø uptake of
AC, a process initiated by changes on the AC surface (referred
to as “eat me” signals) that induce its adhesion to the phago-
cyte. This interaction is mediated by phagocyte receptors that
bind the AC directly or via a variety of opsonizing proteins,
which bridge apoptotic ligands and the receptor. The best-
characterized AC eat-me signal is the exposure of phosphati-
dylserine (PS) on the outer leaflet of the AC plasma membrane
[26]. The “tether and tickle” model of AC ingestion [27]
postulates that initial AC adhesion via multiple redundant
receptors is followed by triggering via stereospecific recogni-
tion of the exposed PS [28]. Although it has since become
evident that the original gene identified as this PS receptor [29]
appears not to encode a cell-surface receptor (reviewed in ref.
[30]), three groups have recently identified novel and unrelated
PS-binding receptors: T cell Ig- and mucin domain-containing
molecule [31], brain-specific angiogenesis inhibitor 1 [32], and
stabilin-2 [33]. It appears likely that PS recognition will prove
to be central to AC ingestion [34].
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However, a bewildering array of other phagocyte receptors of
unrelated molecular classes has also been implicated in AC
uptake [26, 35, 36], in some cases based on antibody-blocking
not corroborated by more definitive experiments using gene-
targeting or peptide-domain modification. Such putative AC
receptors include lectins, the vitronectin receptor, scavenger
receptors of several classes, CD14, and CD91 (reviewed in ref.
[37]). The key question of how these many receptors may
interact to induce AC ingestion and subsequent immunoregu-
latory effects is only beginning to be understood [15, 38, 39].
That some of these receptors may be nonessential for the
decision by the phagocyte to ingest the AC is suggested by the
finding that expression of individual receptors can increase AC
adhesion with minimal effects on uptake [40]. One reason for
this apparent redundancy might be that receptor expression
and possibly use are tissue-, cell type-, and condition-depen-
dent [41]. An alternative, not mutually exclusive, reason could
be that efficient Mø ingestion of AC benefits from the integra-
tion of signals from multiple receptors, some possibly not
specific for the apoptotic state.
Scavenger receptor A (SR-A) I/II is a multifunctional Mø re-
ceptor [42, 43] that is involved in AC clearance, although not
obligatorily [44–46]. SR-A, also known as CD204, is a helically
coiled, homotrimeric, type II integral membrane protein, which
does not bind unmodified PS [47]. SR-A does bind a wide variety
of ligands, most of which are covalently modified molecules [e.g.,
oxidized low-density lipoprotein (LDL)] distinguished from their
native counterparts in part by electrostatic charge [48]. Such
modifications include oxidation and glycation that may be partic-
ularly prevalent under conditions such as cellular stress and
death. Importantly, the amino acid sequence of SR-A contains no
evident motifs associated with intracellular signaling. Thus, de-
spite evidence that SR-A ligation not only induces AC ingestion
but also regulates cytokine and chemokine elaboration [49–51],
how SR-A signals and whether it is yet another potentially redun-
dant AC adhesion receptor are unknown.
By contrast, Mer receptor tyrosine kinase (Mertk; also known as
Tyro12, c-mer proto-oncogene tyrosine kinase, Eyk, and NYK;
Swissprot accession number Q12866) is essential for AC uptake
by murine Mø in vivo and in vitro [3, 52, 53]. Mertk is a large
(200-kDa) transmembrane receptor that binds PS indirectly [via
the serum-derived protein growth arrest-specific gene 6 (Gas6)]
and possesses well-described signaling capabilities [54]. Mertk
contains extracellular Ig and fibronectin III domains (implying
possible cell–cell interactions) and an intracellular, multisub-
strate docking site that can bind Src homology 2-containing pro-
teins such as the p85 chain of the enzyme PI-3K and the adapters
Grb2 and Vav1 [55, 56]. As a receptor tyrosine kinase (RTK) of
the Tyro3 family, Mertk can phosphorylate and activate multiple
downstream signaling intermediaries. Stimulation of a chimeric
receptor containing the Mertk intracellular domain phosphory-
lated PI-3K p85, Grb2, Raf-1, Shc, phospholipase C (PLC), and
ERK [57]. We have previously reported that Mertk is not required
for AC adhesion by murine tissue Mø and that exposure of murine
peritoneal Mø (PMø) to AC sequentially induces tyrosine phos-
phorylation of Mertk, association of Mertk with PLC2, the prin-
cipal PLC isoform in murine Mø, and tyrosine phosphorylation of
PLC2 [58, 59]. Collectively, these characteristics indicate that
Mertk plays a central role in signaling during AC recognition.
We hypothesized that on Mø contact with AC, SR-A might
interact with and signal via Mertk. To test this hypothesis, we
examined the interactions of SR-A and Mertk in murine Mø
cell line J774A.1 (J774), which avidly ingests AC in a Mertk-
dependent manner [59, 60], and in resident murine tissue Mø
of wild-type and SR-A gene-targeted mice. Using immunopre-
cipitation, Western blotting, and functional assays of in vitro
phagocytosis and adhesion, we provide evidence that SR-A
signaling during AC ingestion involves Mertk and PLC2.
MATERIALS AND METHODS
Reagents
The following reagents were purchased from the indicated vendors: PBS
without cations, DMEM, FBS, and penicillin/streptomycin from Life Technol-
ogies (Rockville, MD, USA); sodium orthovandadate, sodium fluoride, octyl-
-D-glucopyranoside (OG), fucoidan, heparin, dextran sulfate, BSA Fraction
V, dexamethasone, 2-ME, glycerol, NaCl, Tris HCl, and phosphatase inhibitor
cocktail II from Sigma Chemical Co. (St. Louis, MO, USA); rat anti-SR-A
antibody (clone 2F8) from Serotec (Raleigh, SC, USA); goat anti-SR-A anti-
body and polyclonal goat anti-Mertk antibody from R&D Systems (Minneap-
olis, MN, USA); anti-CD36 from BD PharMingen (San Jose, CA, USA);
polyclonal rabbit anti-PLC2 antibody (sc-407), anti-actin antibody, rat IgG,
mouse IgG, protein L-agarose, protein G-agarose, and HRP-conjugated anti-
rabbit and anti-goat IgG from Santa Cruz Biotechnology (Santa Cruz, CA,
USA); anti-phospho (p)Mertk antibody from FabGennix Inc. (Frisco, TX, USA);
SDS, 0.2 m polyvinylidene difluoride (PVDF) membrane, nonfat dry milk
blocker, and 7.5% acrylamide Ready Gels from BioRad (Hercules, CA, USA);
Supersignal West Femto maximum sensitivity substrate and TBS, pH 7.2, from
Pierce (Rockford, IL, USA); and Kodak X-Omat AR film and eight-well
Lab-Tek slides from Fisher Scientific (Chicago, IL, USA).
Mice
SR-A/ mice on a 129/SvJ strain background, the generous gift of Dr.
Willem J. S. de Villiers (University of Kentucky Medical Center, Lexington,
KY, USA), were bred locally at our facility. Specific pathogen-free, female
mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA; 129P3/J
strain) or Charles River Laboratories Inc. (Wilmington, MA, USA; C57BL/6
strain) at 7–8 weeks of age and were used at 8–14 weeks of age. Mice were
housed in the Animal Care Facility at the Ann Arbor VA Medical Center (Ann
Arbor, MI, USA), which is fully accredited by the American Association for
Accreditation of Laboratory Animal Care. This study complied with the Na-
tional Institutes of Health “Guide for the Care and Use of Laboratory Animals”
(Department of Health, Education, and Welfare, Publication No. 80-32) and
followed a protocol approved by the Animal Care Subcommittee of the local
Institutional Review Board.
Preparation of AC
All thymocytes were obtained from unmanipulated C57BL/6 mice, which were
killed humanely by rapid asphyxia in a high CO2 environment. Thymuses were
harvested and minced to yield a single-cell suspension. To induce apoptosis,
thymocytes were resuspended in complete medium to a concentration of 1 
106 cells/ml and incubated for 5 h in complete medium containing 1 M
dexamethasone. This treatment yields a population with a low degree of
contamination by late apoptotic or necrotic cells [60, 61].
Preparation of activated Mø and PMø
129/SvJ SR-A/ mice and wild-type 129P3/J mice were killed by asphyxia
in a high CO2 environment. PMø were collected by peritoneal lavage using a
total of 10 ml PBS-EDTA, which was administered in 2 ml aliquots. PMø
among the lavage cells were isolated by plastic adherence with an overnight
incubation in complete medium in a 5% CO2 environment at 37°C. Nonad-
herent cells were removed by gentle washing.
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Cell line
The J774 cell line was obtained from American Type Culture Collection
(Manassas, VA, USA). These Mø were grown in 150 cm2 plastic flasks in
DMEM high-glucose medium containing 10% heat-inactivated FCS and 100
units/ml penicillin/streptomycin. The cells were incubated at 37°C in air
(95%)-CO2 (5%) in a humidified incubator. Cells were removed from the flasks
by scraping and plated at 10–15  106 in a 100-mm plate (for immunopre-
cipitation and Western blot) and used for experiments (immunoprecipitation,
Western blot, phagocytosis, and adhesion assays) after 24 h adherence.
Immunoprecipitation
For immunoprecipitation studies, J774 cells or Mø from SRA/ mice or
wild-type 129P3/J mice were exposed to apoptotic thymocytes in a 1:5 ratio for
various times. For blocking experiments, J774 were preincubated with anti-
SR-A or rat IgG (20 g/ml) for 45 min. For lysis, J774 were washed gently
three times using cold PBS with 10 mM sodium vanadate and 50 mM sodium
fluoride (phosphatase inhibitors) and then lysed for 30 min on ice using cold
OG buffer, which contained 1.5% OG, 50 mM Tris HCl, pH 8.0, 150 mM NaCl,
5 mM EDTA, 10% glycerol, protease inhibitor cocktail II (1:100, Sigma
Chemical Co.), and phosphatase inhibitors, as above. Cells were drawn twice
into a 3-ml syringe via a 25-G needle. The lysed cells were centrifuged at
13,000 g for 10 min at 4°C. To preclear lysed cell supernatants, one of the
following combinations was added: 5 g mouse IgG and 40 l protein G
agarose (for phosphorylation studies) or 5 g goat IgG and 40 l protein
G-agarose (for association studies). Cell lysates were rocked for 30 min at 4°C
and then were centrifuged at 2090 g for 5 min at 4°C. The pellets were washed
twice in OG buffer, and the supernatants were combined. The immunoprecipi-
tating antibody (6 g) was added to the combined supernatants, and the
mixture was rocked overnight at 4°C. Next, 40 l protein G agarose was added,
and the mixture was rocked for 2 h at 4°C. Finally, the protein bound to the
agarose conjugate was centrifuged at 2090 g for 5 min at 4°C, and the pellet
was washed twice using OG buffer.
Western analysis
To run samples on SDS-PAGE, 15 l 5 SDS-PAGE sample buffer and 7 l 1
M DTT were added to the pellet from immunoprecipitation, and samples were
heated at 90°C for 5 min. The samples were centrifuged at 2090 g for 5 min at
room temperature, and the supernatant was saved for SDS-PAGE. Protein from an
equal number of cells (for immunoprecipitation and expression of pMertk) or an
equal amount of protein (for expression of SR-A or Mertk) was loaded onto 7.5%
acrylamide Ready Gels (Bio-Rad), run at 150 V, and transferred to 0.2 m PVDF
sequencing grade overnight at 30 V in 20% methanol, 25 mM Tris HCl, and 192
mM glycine. Blots were blocked in 5% milk, 0.1% Tween TBS (blocker) for 45 min
at room temperature. Primary antibody was added in optimal dilution in blocker
and incubated overnight at 4°C. Blots were washed five times for 15 min each
using Tween-TBS. Secondary antibody was added in blocker, incubated for 45 min
at room temperature, and washed five times for 15 min each using TBS-Tween.
Blots were stained for 5 min at room temperature using Pierce Supersignal West
Femto detection systems. Control blots stained with the secondary antibody alone
showed no staining.
Flow cytometry
J774 were washed twice in staining buffer (Difco, Detroit, MI, USA), resus-
pended in 100 l staining buffer, and incubated for 30 min at 4°C in the dark
with labeled antibodies diluted in 100 l staining buffer. Final antibody
concentrations were 1–2 g/106 cells. FcR was blocked using mAb 2.4G2
(anti-CD16/32) for all primary mAb. After incubation, cells were washed twice
in staining buffer, resuspended in 0.5 ml staining buffer, and analyzed imme-
diately. Flow cytometry was performed as described previously in detail [62]
using a FACScan cytometer (Becton Dickinson, Mountain View, CA, USA)
running CellQuest software on a PowerPC microcomputer (Apple, Cupertino,
CA, USA) for data collection and analysis. A minimum of 10,000 viable cells
was analyzed to determine cell-surface receptor expression.
Phagocytosis assay
AC phagocytosis in vitro was assayed by coincubation of 1.0  105 J774 with
2.0  106 apoptotic thymocytes for 120 min (J774) at 37°C in 5% CO2 as
described previously [60]. Results are expressed as percentage of J774 con-
taining at least one ingested AC (percent phagocytosis) and as phagocytic
index, which was generated by multiplying the percentage of phagocytosis by
the mean number of ingested AC per Mø. Antibody (20 g/ml) or SR-A ligands
(150 g/ml) were added 30 min before addition of AC at concentrations
previously found to be inhibitory.
Adhesion assay
Adherence of AC to J774 in vitro was assayed in the same manner as
phagocytosis, except that 1  107 apoptotic thymocytes were added to each
well, yielding a 100:1 thymocyte:Mø ratio [58]. The slides were incubated for
15 min at 37°C and then washed in a standardized manner by dipping
individual slides in each of two Wheaton jars filled with ice-cold PBS, and
stained using H&E (Richard-Allan, Kalamazoo, MI, USA). These assay con-
ditions have been found to be optimal (unpublished observation). In previously
published experiments, we definitively excluded a contribution of ingested
cells at this time-point using a fluorescence approach that permitted complete
quenching of extracellular AC [58]. Additionally, we verified that under these
conditions, interference by any viable thymocytes in the AC mixture is negli-
gible [58]. Adhesion was evaluated by counting 200 J774 per well at 1000
magnification under oil immersion and scoring for bound thymocytes. Results
are expressed as percentage of J774 binding at least one AC (percent adhesive
Mø) and as adhesion index, which was generated by multiplying the percentage
of adherence-positive Mø by the mean number of adherent AC per Mø.
Statistical analysis
Data are expressed as mean  SEM. Statistical calculations were performed
using Statview 5.0 (SAS Institute, Cary, NC, USA) on a Macintosh Power PC
G4 computer. Continuous ratio scale data were evaluated by ANOVA with
post-hoc analysis by the two-tailed Dunnett test, which specifically compares
treatment groups with a control group [63]. Use of this parametric statistic was
deemed appropriate, as phagocytosis of apoptotic thymocytes by PMø has been
shown to follow a Gaussian distribution [64]. Significant differences were
defined as P  0.05.
RESULTS
SR-A is expressed strongly on the surface of
J774 Mø but not by apoptotic thymocytes
To determine the relative expression of SR-A by J774 and
apoptotic thymocytes, we used Western blot analysis of equal
amounts of protein from each cell type (Fig. 1A). Results
confirmed that J774 strongly expressed SR-A. Apoptotic thy-
mocytes did not express SR-A (Fig. 1A), making it unlikely
that any residual, adherent thymocytes remaining after washing
would contribute to our analysis of SR-A. Flow cytometric
analysis confirmed that J774 expressed SR-A on the cell
surface (Fig. 1B).
Anti-SR-A and SR-A ligands significantly reduce
J774 phagocytosis but not adhesion of AC
To verify the importance of SR-A in the phagocytosis of AC by
the J774 cell line, we measured phagocytosis in the presence
of anti-SR-A, control rat IgG, or functional SR-A ligands.
Pretreatment with anti-SR-A or with the SR-A ligands dextran
sulfate and fucoidan significantly inhibited phagocytosis of AC
by J774, whereas pretreatment with the control compounds
BSA, heparin, and anti-CD36 did not (Fig. 2A). By contrast,
SR-A inhibition had no effect on adhesion of AC by J774 (Fig.
2B). Thus, J774 appears to use other receptors for AC adhesion
but uses SR-A in signaling, which leads to AC uptake in
agreement with previous reports using thymic Mø in vitro [44].
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SR-A and Mertk physically associate in response
to AC
To determine whether SR-A and Mertk associate in response to
exposure to AC, we used an immunoprecipitation approach
(Fig. 3). We found that there was slight association of SR-A
and Mertk in untreated J774 but that association increased
after AC addition at 5, 10, and 30 min and regressed at 60 min
(Fig. 3A). This finding was confirmed by reversing the IP and
IB antibodies, which showed slight association of SR-A and
Mertk in untreated J774 but increased association at 5 and 10
min after AC addition (Fig. 3B). Exposure to AC also induced
increased association of Mertk and SR-A in PMø from wild-
type mice (Fig. 3C); as expected, no band was detected regard-
less of exposure to AC in PMø of SR-A/ mice, which
verified that the band seen at 89 kDa was indeed SR-A.
There was no association of Mertk and SR-A in preparations of
apoptotic thymocyte alone (data not shown), as that cell type
lacks Mertk and SR-A. Therefore, exposure to AC induces the
association of SR-A and Mertk (which could be direct or via
another intermediary protein), potentially focusing the kinase
on specific intracellular substrates.
SR-A inhibition blocks Mertk and PLC2
phosphorylation in J774 in response to AC
We previously reported that after AC, adhesion to Mø Mertk
becomes tyrosine-phosphorylated (an event essential for develop-
ment of its kinase activity as well as to activate its multisubstrate-
docking site), followed by physical association with and tyrosine
phosphorylation of PLC2 [59]. Using a molecular approach, the
Birge laboratory [65] has recently demonstrated that Tyr867 of
Mertk directly mediates the tyrosine phosphorylation of PLC2 in
response to the AC-binding Mertk ligand Gas6. Therefore, having
shown that SR-A and Mertk associate, we asked whether anti-
SR-A could block these sequential phosphorylation events. Im-
munoprecipitation with anti-pTyr and Western blotting with anti-
Mertk showed no detectable pMertk at baseline, but rapid induc-
tion of phosphorylation in J774 exposed to apoptotic thymocytes
for 5, 10, and 20 min (Fig. 4A, upper gel). This AC-induced
phosphorylation of Mertk was substantially inhibited by soluble
anti-SR-A at 5 and 10 min and was strongly reduced at 20 min.
To confirm these results, we performed Western blotting with
Fig. 2. Anti-SR-A and function-blocking SR-A ligands reduce phagocytosis
but not adhesion of AC by the J774 Mø cell line. J774 (1105 cells/well) were
adhered overnight to eight-well chamber slides in medium containing 10%
FBS and then were preincubated for 30 min at 37°C and 5% CO2 in medium
containing rat IgG (Control), anti-CD36, anti-SR-A (each at 20 g/ml final
concentration), or SR-A ligands (250 g/ml final concentration). Next, without
washing, AC were added as 4  106 cells/well for 120 min for phagocytosis
assay (A) or as 2  107 cells/well for 15 min for adhesion assay (B).
Phagocytosis and adhesion were determined by examining H&E-stained slides
under oil immersion. (A) Phagocytic index (right panel) and percentage of
phagocytic Mø (left panel). Data are mean  SEM of three to six replicates. *,
P  0.05, compared with control, ANOVA with post-hoc testing by the
two-tailed Dunnett test. (B) Adhesion index (right panel) and percentage of
adhesion-positive Mø (left panel). Data are mean  SEM of three replicates per
condition in a single experiment.
Fig. 1. SR-A is expressed strongly by J774 but not by AC. (A) Western
blotting. The murine Mø cell line J774 and apoptotic thymocytes (AC) from
normal C57BL/6 mice were lysed, and equal amounts of protein were run on
a 7.5% polyacrylamide gel under reducing conditions and were transferred to
PVDF. Blots were blocked and probed with the anti-SR-A mAb 2F8 diluted in
blocker. Blots were then washed for 15 min using Tween-TBS and incubated
with HRP-conjugated donkey, anti-rat IgG diluted in blocker, and the signal
was detected by ECL. To demonstrate protein loading, blots were then stripped
and reprobed using anti-actin antibody. (B) Flow cytometry. J774 were stained
with anti-SR-A (filled profile) or with isotype-matched control rat IgG (open
profile). Representative histograms are shown. FL2-H, Fluorescence 2-height.
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anti-pMertk of J774 cell lysates exposed to AC. These lysates
showed limited pMertk at baseline but induction of phosphoryla-
tion at 5, 10, and 20 min (Fig. 4B, upper gel). Once again,
AC-induced phosphorylation of Mertk was substantially inhibited
by soluble anti-SR-A at 5 and 10 min and at 20 min. The rat IgG
did seem to induce some Mertk phosphorylation in comparison
with control conditions lacking any Ig, presumably as a result of
Fc effects. Collectively, these results imply that SR-A function is
essential for the prompt and optimal activation of Mertk by AC.
We next examined whether anti-SR-A also blocks PLC2
phosphorylation in response to AC, by reblotting with anti-
PLC2. Some basal phosphorylation of PLC2 was detectable
in J774 lysates without exposure to AC, but phosphorylation
increased at 5 and 10 min after AC addition (Fig. 4A, lower
gel). PLC2 phosphorylation in response to AC was almost
entirely blocked by anti-SR-A preincubation. We have previ-
ously reported that apoptotic thymocytes themselves show un-
detectable phosphorylation of PLC2 [59].
Mertk phosphorylation in response to AC
exposure is reduced in Mø of SR-A/ mice
It was previously reported that SR-A/ Mø show a 50%
reduction in apoptotic thymocyte uptake in vitro [44]. To
correlate this finding with changes in SR-A signaling through
Mertk, we exposed PMø from wild-type mice or SR-A/
mice to AC and measured Mertk tyrosine phosphorylation,
which increased in PMø of wild-type mice at 10, 30, and 60
min after AC exposure, whereas this increase was reduced
severely in PMø of SR-A/ mice (Fig. 5A). Western blotting
showed that this difference was not a result of inadequate
expression of Mertk in SR-A/ mice, in which the RTK was
actually relatively increased (Fig. 5B). To confirm these results
using an alternative design, we also exposed PMø of SRA/
mice and wild-type mice to AC in vitro and performed Western
blotting with anti-pMertk. Wild-type PMø lysates showed lim-
ited pMertk at baseline but induction of phosphorylation at 10
and 20 min. This AC-induced phosphorylation of Mertk was
inhibited substantially in SR-A/ PMø (Fig. 5C). Therefore,
optimal tyrosine phosphorylation of Mertk in response to AC in
vitro in mature murine PMø is dependent on SR-A expression.
Ingestion of AC by PMø of SR-A/ mice is
delayed but not abolished
Finally, we examined how genetic absence of SR-A influenced
the kinetics of AC ingestion in vitro, using resident PMø from
Fig. 3. Exposure of J774 to AC induces association of SR-A and Mertk. Equal
numbers of J774 (A and B) or PMø from 129P3/J or SR-A/ mice (C) were
stimulated in vitro with a fivefold excess of AC for various times as indicated,
washed extensively, and then lysed in OG buffer. After preclearing, Mø lysates
were immunoprecipitated (IP) using anti-Mertk (A and C) or goat anti-SR-A (B)
and protein G-agarose, run on a 7.5% acrylamide gel under reducing condi-
tions, and transferred to PVDF. Blots [immunoblots (IB)] were then blocked
and probed using rat anti-SR-A (A and C) or anti-Mertk (B) and washed for 15
min using Tween-TBS. After incubation with HRP-conjugated anti-rat or
anti-goat IgG in blocker, signal was detected by ECL. Finally, to demonstrate
protein loading, blots were stripped and reblotted with anti-Mertk (A and C) or
rat anti-SR-A (B). In each case, similar results were obtained in an additional
experiment of identical design. wt, Wild-type.
Fig. 4. Anti-SR-A inhibits the AC-induced tyrosine
phosphorylation of Mertk and PLC2. Equal num-
bers of J774 were preincubated at 37°C and 5% CO2
in medium containing 20 g/ml rat IgG or anti-SR-A
and after washing, were stimulated in vitro with a
fivefold excess of AC for various times as indicated,
washed extensively, and then lysed in OG buffer.
After preclearing, Mø lysates were (A) immunopre-
cipitated using anti-pTyr antibody (anti-pY) and pro-
tein G-agarose and run on a 7.5% acrylamide gel
under reducing conditions and transferred to PVDF
or alternatively, (B) run directly on a 7.5% acryl-
amide gel. Blots were then blocked and probed using
anti-Mertk (A) or anti-pMertk (B) and washed for 15
min using Tween-TBS. After incubation with HRP-
conjugated anti-goat (for detection of Mertk) or anti-
rabbit (for detection of PLC2) IgG in blocker, signal
was detected by ECL. Finally, blots were stripped
and reblotted with anti-PLC2 (A) or anti-Mertk (B). Similar results were obtained in an additional experiment of identical design.
514 Journal of Leukocyte Biology Volume 84, August 2008 http://www.jleukbio.org
untreated mice. Results showed that the phagocytic index was
reduced significantly at early time-points (30 and 45 min) in
PMø of SR-A/ mice but that there was no significant
difference at 60 min (Fig. 6). The eventual ability of Mø to
ingest AC, despite the absence of SR-A in this kinetic exper-
iment, correlates with the absence of an AC clearance defect in
vivo [45], an example of the redundancy in AC clearance
mechanisms.
DISCUSSION
The results of this study indicate that during AC-induced
signaling and the resulting phagocytosis of AC by murine Mø,
SR-A rapidly, physically associates with the receptor Mertk,
directly or indirectly, and is essential for optimal Mertk acti-
vation. Soluble anti-SR-A blocked two known key early events
during AC ingestion: the sequential tyrosine phosphorylation of
Mertk and of PLC2 [59] as well as AC phagocytosis itself.
AC-induced tyrosine phosphorylation of Mertk on tissue Mø of
SR-A/ mice was reduced in magnitude and duration rela-
tive to Mø of wild-type mice. We also found that SR-A, like
Mertk itself, was not essential for Mø adhesion of AC, which is
noteworthy given the known role of SR-A in mediating cation-
independent adhesion to a wide range of substrates [66–68].
These results advance understanding of the earliest signaling
steps in phagocytosis of AC by Mø, an event with important
immunoregulatory consequences.
Defining how SR-A participates in Mø signal transduction is
particularly important as a result of the central role of this
highly versatile scavenger receptor in host defense, atherogen-
esis, and neoplasia [68–72]. The most common approach to
this question has been to examine effects of nonselective SR
ligands, such as fucoidan, polyinosinic:polycytidylic acid, or
acetylated LDL using Mø [73–76] or cell lines transfected with
SR-A [75, 77]. Interpretation of these studies is hampered by
the lack of specificity of such ligands, which can bind to other
scavenger receptors. This caveat remains even when they are
tested on SR-A/ Mø [78, 79] as a result of compensatory
up-regulation of alternative receptors [46]. To avoid these
issues, we, like other recent investigators [49], primarily used
the specific function-blocking mAb 2F8. As this approach has
potential problems as a result of FcR ligation, we used IgG as
a control in the blocking experiments.
Our finding of a role for SR-A in Mø uptake of AC in vitro
agrees with and extends previous results using mAb 2F8 on
thymic and elicited Mø of wild-type mice and Mø from SR-
A/ mice [44]. The exact role of SR-A in AC clearance in
vivo remains uncertain. SR-A/ mice have no developmen-
tal abnormalities [46] and show normal clearance of AC within
the thymus [45] (although clearance in other organs has not
been reported). However, these observations might reflect com-
pensatory changes in alternative AC receptors, such as CD36,
which is up-regulated in fetal Mø of SR-A/ mice [80], or
efficient AC uptake by cell types other than Mø [81], as occurs
in some organs [5, 7, 8, 82]. It is clear that SR-A is strongly
expressed primarily by cell types that avidly engulf AC [46,
83]. These results are, to our knowledge, the first demonstra-
tion of an interaction (direct or indirect) between SR-A and a
RTK. A variety of previous studies [75, 76, 84, 85] has pro-
vided indirect evidence that SR-A associates with tyrosine
kinases, based in most cases on inhibitor studies and use of
Fig. 6. AC phagocytosis by resident PMø is delayed in the absence of SR-A.
In vitro phagocytosis of AC by resident PMø from wild-type mice (f) or
SR-A/ mice () was assayed at various times from 30 to 90 min after
addition of a fivefold excess of AC. *, Significantly different; P  0.05,
ANOVA with post-hoc analysis by the two-tailed Dunnett test.
Fig. 5. Mertk phosphorylation is inhibited in tissue Mø of SR-A/ mice.
(A) Coimmunoprecipitation of PMø following AC exposure. PMø from 129P3/J
mice (upper gel) or SR-A/ mice (lower gel) were exposed to fivefold excess
of AC for various times as indicated. Cells were lysed, pTyr immunoprecipi-
tates formed, and gels were probed with anti-Mertk and developed as described
in the legend to Figure 3. The experiments shown were repeated in two
additional experiments with similar results. (B) Western blot. PMø lysates (40
g protein) from wild-type 129P3/J mice or SR-A/ mice were run on a
4–20% acrylamide gel, and gels were transferred and blocked as described in
the legend to Figure 4 and probed with anti-Mertk, followed by stripping and
reprobing with anti-actin. (C) Western blot. PMø lysates from wild-type
129P3/J mice or SR-A/ mice were run on a 4–20% acrylamide gel, and
gels were transferred and blocked as described in the legend to Figure 4 and
probed with anti-pMertk, followed by stripping and reprobing with anti-Mertk.
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nonspecific SR-A ligands. Although we did find that one re-
lated RTK, STK/RON [86], was not activated on direct activa-
tion of SR-A using immobilized anti-SR-A (data not shown), it
is unlikely that Mertk is unique in associating with SR-A; e.g.,
the cytoplasmic tyrosine kinase Lyn was coimmunoprecipitated
using polyclonal rabbit anti-human SR-A antiserum within
30 s of exposing the Mø cell line THP-1 to acetyl LDL [87].
Conversely, SR-A is a target of serine phosphorylation by
JNK2 [88], and Gas6, a Mertk ligand, can induce SR-A ex-
pression in human smooth muscle cells via a pathway requiring
the serine/threonine kinase AKT [89].
Our findings imply that SR-A participates in optimal AC
uptake by aggregating Mertk monomers to facilitate their au-
totransphosphorylation. Such an accessory action of SR-A
could be important to initiate Mø signaling, which leads to
phagocytosis of AC, as the Biacore assay has shown that Mertk
interacts with low avidity with its soluble AC-binding interme-
diaries, Gas6 and protein S [90–92]. Activated Mertk provides
multiple signals to initiate AC uptake, including release of
VAV1 constitutively bound to inactive Mertk, freeing that
guanine exchange factor to hydrolyze the RhoA family mem-
bers [56]; activation of PLC2, which by releasing diacylglyc-
erol and inducing Ca		 transients, recruits protein kinase C


 to the nascent AC phagosome [59, 93]; and Src-mediated
tyrosine phosphorylation of focal adhesion kinase and its re-
cruitment to the v5 integrin [94]. This final step is partic-
ularly important, as it induces formation of the p130(CAS)/
CrkII/Dock 180 signaling complex that activates Rac-1 and
hence, actin polymerization. A recent paper identified Tyr867
of Mertk as required for activation of PI-3K and PLC2 [65]. In
that study, PLC2 phosphorylation in response to the PS-
binding Mertk agonist Gas6 was abrogated completely in the
CD8-Mertk Y867F mutant or CD8-MertkKD cells. The many
consequences of Mertk activation place it at the center of the
AC uptake process. Hence, data from this study and others,
showing that SR-A is not obligatory for efficient AC uptake
[44–46], imply that other receptors will be able to increase the
efficiency of Mertk autotransphosphorylation during AC recog-
nition.
A final aspect of these results is the insight they provide on
the unique activation state induced by Mø contact with AC
[11–20]. SR-A was the first pattern recognition receptor to be
shown to counteract proinflammatory receptors [50, 95, 96],
although the signaling pathways involved remain incompletely
defined. SR-A/ mice and gene-targeted mice with defective
Mertk expression exhibit increased sensitivity to endotoxin-
induced shock, related to increased TNF- production [95,
97]. Significantly, two groups have recently shown an essential
role for Mertk, along with other members of the Tyro3 family of
RTKs, to which it belongs, for the ability of AC exposure to
block subsequent proinflammatory cytokine production by den-
dritic cells (DC) [39, 98]. Whether immunosuppressive effects
of SR-A activation by others of its many ligands depend on
signaling via Mertk will require further study.
In summary, we provide evidence that SR-A, a receptor with
broad ligand-binding properties and a central role in host
defense, pairs with Mertk during signaling induced by AC,
which leads to Mø ingestion of AC. This intermolecular inter-
action, likely induced when the two receptors bind their own
cognate ligands on the AC surface, illustrates how a receptor
with multiple ligands can participate in delivery of a specific
signal through its binding partners. Defining the exact impor-
tance of SR-A in uptake of AC by Mø and DC in different
organs will require additional in vivo experimentation. Under-
standing the signaling pathways induced during AC clearance
is a first step to manipulate the process therapeutically.
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